Reports
Reports
Reports
Topics
Topics
Topics

The New Frontier - Your weekly science and innovation update - 7th July 2026

Your weekly pulse check on science and innovation. Those on the supply side of real estate can track the trends set to drive demand, while occupiers gain fresh perspective on competitor activity and sector dynamics.

Written by:

8 mins read

Britain’s new arsenal of autonomy

Britain has placed a sizeable bet on machines that fly, sail and drive themselves. The Defence Investment Plan commits £298bn over four years, of which £15bn is new money layered on top of last year’s Spending Review, and it lifts annual defence spending from £54bn to almost £80bn by the end of the decade. Core spending is to reach 2.7% of GDP from 2027-28, with a declared path to 3% in the next parliament and an allied pledge of 3.5% by 2035. The awkward question is who pays: £4.7bn remains unfunded and is destined for Andy Burnham’s desk at Budget 2026.

The most eye-catching pledge is more than £5bn for a drone transformation. It spans £650m for cheap, expendable systems for the Army and Special Forces, £220m for armed drones to fly alongside Apache helicopters, £200m for counter-drone capability and a hybrid Royal Navy in which crewed vessels work with uncrewed missile and submarine-hunting platforms. A further £2bn is earmarked for an AI-enabled digital targeting web, meant to connect sensors, decision-makers and weapons more quickly. The Ministry of Defence (MoD) has also opened a Defence Uncrewed Systems Centre in Swindon and stood up an Uncrewed Systems Taskforce to embed the technology across the Armed Forces. The logic is written in the skies over Ukraine and the Middle East, where recent conflicts have shown how warfare has changed.

Public money and private capital are now hardening into physical demand. By 2025, global venture capital investment in defence tech had more than doubled from 2020 levels, rising from $20.9bn across 790 deals to $53.2bn across 1,066 deals. Much of that is going to autonomous systems. Germany’s Helsing has opened its first UK resilience factory in Plymouth to build AI-enabled submarine-hunters. America’s Anduril, valued at $61bn after raising $5bn in May, is hunting for a British drone-production site. Portugal’s Tekever is expanding in Swindon, beside a new uncrewed systems test centre billed as Europe’s largest. Cambridge Aerospace recently acquired space in Cambridge. Ukraine’s biggest drone manufacturer opened a factory in Suffolk. StirlingX has just raised £15m to scale its data intelligence platform and UK operations, and Arondite has opened a London office with plans to invest £100m in its British operations over the next five years.

In May, the MoD awarded contracts to 13 British innovators in its search for the next defence unicorns. Several sit in autonomous systems, including RC Den, Aether Aerospace and SpaceAM. Chris Isaac, SpaceAM’s CEO and founder, described the impact in blunt terms: “Game changer! In just five weeks: six new staff, our first commercial labs operational, top London VCs lining up to invest, and the ability to scale at pace with confidence. That’s what this Unicorn Fund has delivered.”

For real estate, all these points lead to a new ecosystem of development, testing, assembly and manufacturing space. Defence tech occupiers will want secure sites, engineering offices, test ranges and segregated airspace in which to fly drones legally. Naval autonomy makes different demands, including deepwater access and vessel storage, which turns places such as Plymouth, Portsmouth and Scotland’s coast into natural centres of gravity. Power matters just as much. Simulation and AI training require high-performance computing, pitting defence tech firms against the hyperscalers in the scramble for powered land and grid connections. At the hardware end, demand will centre on light industrial and R&D space, with 3D printing, drone production lines and logistics able to move a product from prototype to volume in weeks.

Clustering will follow the sites suitable for such work and will also be driven by access to talent, research and innovation networks and, in some cases, proximity to defence customers. The government is helping shape where defence tech happens, partly through a series of Defence Growth Deals. Plymouth has been designated a centre for the maritime autonomous systems sector, and Wales has been identified as a leader in UAV development and testing, equipped with testing sites including the Snowdonia Aerospace Centre and academic institutions such as the Welsh Centre for Defence Autonomy.

For those looking for a visual look at what the real estate product looks like, an interesting video on Anduril’s space in the US. Arsenal-1 | Anduril

Starmer’s unfinished ledger and the Burnham prospectus

Two reports this week take the measure of Starmer’s record on technology and innovation. Beauhurst finds the stock of active British companies has grown since he took office, with genuine momentum in the industrial strategy’s priority sectors, notably digital technology and defence. Yet the number of patent-holding firms has slipped by 6%, academic spinouts by 3%, and R&D-grant winners by 4%.

TechUK’s one-year review of the digital plan credits finance, AI and quantum as the standout gains: the British Business Bank is more visible, pension capital is at last reaching scale-ups, and a £2bn quantum package, well above the £670m first pencilled in, has given the sector confidence to build. The weakness is the cost of doing business. Some 37% of tech firms name energy costs as Britain’s single greatest drawback, the highest score in the survey, and 56% say the current environment makes expansion hard. Fix it, grid included, and 74% say they would grow.

Enter Andy Burnham, whose team is already redrawing the innovation map. The first move is sovereignty. The Financial Times reports that his circle, including the former technology minister Josh Simons, is reworking the national AI strategy away from what it calls a US-centric model and towards British firms and workers. Tilting procurement so that homegrown firms win the big government contracts now going to American rivals could help shed Britain’s reputation as a taker rather than a maker. The risk is that it also deters the foreign investment the country still needs, so the balance is a fine one.

The second move is geography. Burnham’s “Manchesterism”, forged over nine years as mayor, would anchor local economies in universities and consolidate public and private investment at the city-region level; he wants a “Number 10 of the north” to help every region set credible industrial ambitions, with the Cambridge–Manchester Innovation Partnership as the template for creating complementary clusters. The caveat the research world keeps raising is that dispersing R&D decisions too widely risks fragmenting the national base that keeps British science and innovation globally competitive.

The wider prospectus leans on devolution. In life sciences, that means integrating health and social care and shifting resources out of acute hospitals towards community and preventive care, with the roles of the biggest technology contractors reportedly under review. That tilt towards prevention should widen the runway for life sciences firms built around keeping people well rather than treating them once they are ill. On skills, universities are cast as engines of innovation and economic growth; however, Andy Burnham questions the emphasis on the university route for young people and argues for an education system that treats academic and technical routes as equals, greater partnership between employers and educators, and apprenticeships for 16- to 18-year-olds. All of these points point to a faster roll-out of the current government’s Technical Excellence Colleges, which partner directly with big employers to teach the skills that priority sectors are short of and to a much closer relationship between academia, local government and industry.

In other news

UK firms took the largest share of European venture funding in Q2 2026, accounting for 40% of all capital raised. Five of Europe’s 15 biggest VC rounds went to UK companies, including Isomorphic Labs, Wayve, Ineffable Intelligence, PhysicsX and Oxford Quantum Circuits.

Cambridge biotech Trimtech Therapeutics added $14m to close a $47m seed for its protein-degrader drugs, led by Johnson & Johnson’s venture arm and BGF.

London’s Isometric raised a $40m in Series A for AI carbon certification across the industrial sector.

RQ Bio, a private biotechnology company developing long-acting antibody therapeutics for the prevention of influenza in high-risk and immunocompromised populations, announced the completion of an oversubscribed $115 million (£85.5 million) Series A financing.

On the fund side, London’s Ruya Ventures closed a $50m debut deep-tech fund and Tapestry VC launched an $80m third fund, part-backed by the British Business Bank. The bank has invested £600m in more than 50 UK scale-ups, doubling its equity activity since October.

The Department for Science, Innovation and Technology has signed a non-binding memorandum of understanding with Cisco International to support the government’s AI Opportunities Action Plan. The first phase runs over 18 months and includes establishing Barnsley as the UK’s first Tech Town, with Cisco providing technology and skills courses for residents and organisations.

According to the British Business Bank, Edinburgh has overtaken London as the UK’s leading hub for university spinouts. The University of Edinburgh was named the country’s most active research institution, with 16 spinout deals placing it in the UK’s top three. The city’s momentum was reinforced by Fidra Energy, the Edinburgh-based battery-storage company, which secured £445m — the largest UK seed-stage venture round since 2020.

The Defence Investment Plan includes £580m for a new state-of-the-art facility at the Defence Science and Technology Laboratory site at Porton Down, expanding its work on biological warfare threats.

Oxford and UCL will host new government-backed AI labs focused on next-generation tools for wider use by businesses and public services. Backed by up to £60m and access to large-scale computing power, the labs aim to strengthen the foundations for future AI breakthroughs in Britain.

Anthropic launched an AI drug-discovery programme, joining other tech giants in betting on healthcare.  

Technology Occupier UKCities ScenceandInnovation Investment
Get the latest updates.

Sign up to Knight Frank Research.

Your details

Thank you
for getting in touch

A member of our team will be in touch with you as soon as possible to discuss your enquiry.

We look forward to speaking with you soon.

Your privacy

We take the processing and privacy of your information very seriously. Your data is collected and used in accordance with our terms and conditions and global privacy policy.

This site is protected by reCAPTCHA and the Google privacy policy and terms of service apply.

Sorry!
An unexpected error has occurred.

Please try again later.

Sending your message...
Sending your message...